These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3660405)

  • 21. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
    Seymour AA; Swerdel JN; Abboa-Offei B
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):456-65. PubMed ID: 1711608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.
    Natoff IL; Nixon JS; Francis RJ; Klevans LR; Brewster M; Budd J; Patel AT; Wenger J; Worth E
    J Cardiovasc Pharmacol; 1985; 7(3):569-80. PubMed ID: 2410692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypotensive and physiological effect of angiotensin converting enzyme inhibitory peptides derived from soy protein on spontaneously hypertensive rats.
    Wu J; Ding X
    J Agric Food Chem; 2001 Jan; 49(1):501-6. PubMed ID: 11170618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
    Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J
    Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of acute hemodynamic effects of MC-838, a new angiotensin-converting enzyme inhibitor, with captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Miyamoto Y; Sakanashi M
    Jpn J Pharmacol; 1986 Mar; 40(3):373-80. PubMed ID: 3012164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, CGS 30440, on blood pressure and cardiac hypertrophy in spontaneously hypertensive rats.
    Webb RL; Abramson ML; Beil ME; Odorico LM; Chatelain RE
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):632-42. PubMed ID: 9388046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive and angiotensin converting enzyme inhibitory activities of a novel dihydrobenzofuran analogue.
    Hamilton TC; Howlett DR; Longman SD; Markwell RE; Norton J; Summers DR; Wilson C
    Arzneimittelforschung; 1988 Apr; 38(4):531-6. PubMed ID: 2840917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
    Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
    Li GH; Qu MR; Wan JZ; You JM
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats.
    Rubin B; Antonaccio MJ; Goldberg ME; Harris DN; Itkin AG; Horovitz ZP; Panasevich RE; Laffan RJ
    Eur J Pharmacol; 1978 Oct; 51(4):377-88. PubMed ID: 213296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of a new angiotensin converting enzyme inhibitor: delapril.
    Saruta T; Nishikawa K
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):23S-28S. PubMed ID: 2009144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel antihypertensive hexa- and heptapeptides with ACE-inhibiting properties: from the in vitro ACE assay to the spontaneously hypertensive rat.
    Ruiz-Giménez P; Marcos JF; Torregrosa G; Lahoz A; Fernández-Musoles R; Valles S; Alborch E; Manzanares P; Salom JB
    Peptides; 2011 Jul; 32(7):1431-8. PubMed ID: 21605609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.